Product NDC: | 51079-576 |
Proprietary Name: | Pramipexole Dihydrochloride |
Non Proprietary Name: | pramipexole dihydrochloride |
Active Ingredient(s): | .125 mg/1 & nbsp; pramipexole dihydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51079-576 |
Labeler Name: | UDL Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077854 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101117 |
Package NDC: | 51079-576-20 |
Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-576-20) > 1 TABLET in 1 BLISTER PACK (51079-576-01) |
NDC Code | 51079-576-20 |
Proprietary Name | Pramipexole Dihydrochloride |
Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-576-20) > 1 TABLET in 1 BLISTER PACK (51079-576-01) |
Product NDC | 51079-576 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pramipexole dihydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20101117 |
Marketing Category Name | ANDA |
Labeler Name | UDL Laboratories, Inc. |
Substance Name | PRAMIPEXOLE DIHYDROCHLORIDE |
Strength Number | .125 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |